Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Discover the latest content that has just been published on Research Tree
• The net result swung from a loss of $442m for Q3 22 to a profit of $1.02bn for Q3 23 • The segments participated in the lower claims and higher interest rates • RoI increased from 1.6% for 9M 23 to 3.5% for 9M 23 • Management confirmed the full year profit target of more than $3bn for FY2023
Companies: Swiss Re AG
AlphaValue
• Net profit rose from weak $157m for H1 22 to $1.45bn for H1 23 • RoI was up to 2.8% for H1 23 compared to 1.2% for H1 22 • P&C achieved successful July renewal • Management confirmed the full year profit target of above $3bn for FY2023
• Net premiums earned rose by 4% to $11.1bn for Q1 23 • RoI improved from 0.7% for Q1 22 to 2.8% for Q1 23 • The net result swung from a loss of $248m for Q1 22 to a profit of $643m for Q1 23 • Treaty premium volumes increased by 5% in the April renewals
• Net profit attributable to shareholders decreased by 67% to $472m for 2022 compared to 2021. EPS was only CHF1.63 for FY2022 compared to CHF4.52 for FY2021 • Management proposes a dividend of CHF6.40 per share for FY2022 after CHF5.90 for FY2021. • Swiss Re renewed $10.2bn in premium volume on 1 January 2023, representing an increase of 13%. • Swiss Re targets net income of more than $3bn for 2023 and RoE of 14% for 2024
• Swiss Re estimates its preliminary claims from Hurricane Ian at approximately $1.3bn in Q3 22 • Expected Group net loss of approximately $0.5bn for Q3 22 • ROE target of 10% for 2022 is unlikely to be reached
• Net profit declined by 85% to $157m for H1 22 but Q2 22 profit was $405m • RoI was down to 1.2% for H1 22 compared to 3.2% for H1 21 due to listed equity losses of $426m • P&C achieved a price increase of 12% in July renewal • Shareholders´ equity declined by 37% in H1 22, mainly due to $7.5bn of unrealised investment losses.
• Net premiums earned rose by 4% to $10.6bn • Impact of the COVID-19 on the underwriting result of the group was $524m for Q1 22 • Net result was a loss of $248m for Q1 22 compared to a profit of $333m for Q1 21 • Treaty premium volumes increased by 15% in the April renewals
• Net result increased from a loss of $878m for 2020 to a profit of $1.44bn for 2021. • Management proposed an unchanged dividend of CHF5.90 per share for FY2021. • Swiss Re renewed $8.9bn in premium volume on 1 January 2022, representing an increase of 6%. • Swiss Re announced a new group RoE target of 10% for 2022 and 14% for 2024
• Net premiums earned rose by 6% for 9M 21. • Net result was a profit of $1.26bn for 9M 21 compared to a loss of $691m for 9M 20. • COVID-19-related claims and reserves declined from $3.0bn for 9M 20 to $1.27bn for 9M 21. • Net income of $212m for Q3 21 was above consensus expectations of a loss of $81m.
• Net result was a profit of $1.05bn for H1 21 compared to a loss of $1.13bn for H1 20. • Impact of the COVID-19 crisis on the underwriting result of the group was $870m for H1 21 compared to $2.5bn for H1 20. • Treaty premium remained largely stable but the price improved by a nominal 4% in the July renewals. • Shareholders´ equity declined by 12% in H1 21, mainly due to $2.5bn unrealised investment losses.
• Net premiums earned rose by 7% to $10.2bn • Impact of the COVID-19 crisis on the underwriting result of the group was $643m for Q1 21. • Net result was a profit of $333m for Q1 21 compared to a loss of $225m for Q1 20 • Treaty premium volumes increased by 20% in the April renewals
Net loss was $878m for 2020 and higher than consensus expectations. Management proposed an unchanged dividend of CHF5.90 per share for FY2020. Swiss Re renewed $7.8bn in premium volume on 1 January 2021, representing a decrease of 11%.
• Net premiums earned rose by 6% for 9M 20. • Net result attributable to shareholders was a loss of $691m for 9M 20 compared to net income of $1.34bn for 9M 19. • COVID-19-related claims and reserves rose from $2.5bn for H1 20 to $3.0bn for 9M 20. • Net income of $444m for Q3 20 was above consensus expectations of $248m.
• COVID-19-related claims and reserves rose from $0.5bn for Q1 20 to $2.5bn for H1 20 • Net loss of c.$1.1bn for H1 20 compared to a net profit of $953m for H1 19 • Closing of ReAssure sale pushed the SST ratio above the target level of 220%, despite the significant claims and reserves set up in H1 20
• Net premiums earned rose by 7% to $9.6bn • $476m claims for cancelled or postponed events and a mark-to-market charge of $251m pre-tax due to the decline in the Phoenix share price. • Net result was a loss of $225m for Q1 20 • Treaty premium volumes increased by 4% in the April renewals
Research Tree provides access to ongoing research coverage, media content and regulatory news on Swiss Re AG. We currently have 1 research reports from 5 professional analysts.
Chrysalis Investments’ latest quarterly NAV update showed a 2.9% increase in NAV per share to 147.46p, which reflected uplifts in the carrying values of Starling Bank, Smart Pension, and Klarna (amongst others) and write-downs in wefox and Tactus. The Group’s “likely disposal” is still ongoing, which could result in a sizeable injection of liquidity, taking gross cash to over £70m by our estimate. This would free up c. £20m for share buybacks according to the newly approved policy, which would h
Companies: Chrysalis Investments Limited
Zeus Capital
UK commercial property has been a cornerstone asset for many income-seeking investors (both retail and institutional) in recent decades, particularly since the global financial crisis of 2007/8 and the resulting ultra-low interest rate environment. However, since rates began to rise in 2022 to tackle surging inflation, meaningful returns have once more become available on lower-risk assets such as cash and government bonds, which has led to a retrenchment from alternative income assets such as p
Companies: LABS SREI SUPR AEWU
Capital Access Group
Please find below our weekly update covering themes that we feel that are of interest to investors and participants in the small and mid-cap TMT sector as well as commentary on recent newsflow.
Companies: CPX CNC TRAK CLCO TERN MWE
Allenby Capital
The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices. As a 31-strong group, its combined market capitalisation is no
Companies: AEIT ROOF DGI9 INPP GSF SEIT USFP HICL ORIT BSIF TRIG NESF SEQI HEIT GRP GCP FSFL 3IN AERI PINT RNEW BBGI GSEO DORE TENT GRID CORD HGEN AEET
Hardman & Co
NextEnergy Solar Fund has extended its £70m revolving credit facility by a year to June 2025 and improved the margin by 10bps. Along with the refinancing of £135m announced in April the move shows a willingness amongst lenders to support solar energy and storage on attractive terms in our view.
Companies: NextEnergy Solar Fund Ltd
Longspur Clean Energy
Molten Ventures has recently completed the acquisition of Forward Partners, which allowed Molten to further broaden its portfolio, add a complementary strategy focused on earlier stage companies and potentially provide a pipeline of new core holdings. Furthermore, its recent equity raise gave Molten the funds to pursue new investments in what it currently considers a buyer’s market, with an emphasis on the venture capital (VC) secondary market. In FY24 (to end-March 2024), Molten’s gross portfol
Companies: Molten Ventures PLC
Edison
Companies: Chariot Limited (CHAR:LON)Duke Capital Limited (DUKE:LON)
Cavendish
In this note we look at the gap between perception and reality in the UK equity market, the opportunities and threats in the economic and market outlook, and the emerging consensus that the valuation discount versus other major markets is at or close to an inflection point. We consider the benefits of UK equity strategies both for income investors and for those seeking exposure to the higher growth potential of smaller and mid-cap companies.
Companies: ATS MRCH SCP SHRS LWDB JUGI MINI
The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. For the second year running, apart from global economic influences affecting world markets, performance in 2023 was dented by the capital-intensive nature of the sector. The HHI fell 3.7%, to 483.8, underperforming the main London markets – FTSE 100 (+3.8%) and FTSE All-Share (3.8%) but outperforming the FTSE AIM All-Share Index (
Companies: TXG NDVA TSVT BCOW Z29 TXG NCYT GNS SUN AMS OMG APH EKF EAH IMM AGL DEMG AGY TSTL IPO GDR ETX TRX HVO CTEC AVO OXB DEST VLG IXI VAL INDV AGR AVCT BAI 123F IMCR BCOW
Canadian General Investments (CGI) has delivered a very commendable long-term performance versus the Canadian market. Longstanding manager Greg Eckel at Morgan Meighen & Associates (MMA) is unphased by stock market volatility, following a fundamental, long-term approach to stock selection. He has taken advantage of the maximum 25% permitted allocation to US stocks to increase CGI’s returns, including a position in NVIDIA, which has been in the portfolio since 2016. The manager is unconstrained b
Companies: Canadian General Investments Ltd
Companies: Avation PLC
Canaccord Genuity
Companies: Zegona Communications Plc
Companies: Personal Group Holdings Plc (PGH:LON)Reabold Resources plc (RBD:LON)
Zonal pricing is now under consideration for implementation in the GB power market. While this is very much not a given, this note summarises the key reports on its potential impacts. We find that while there is an overall reduction in revenues across generation, this may be less than originally predicted and new regional price differences and timing differences may favour storage in Scotland and delay new gas plant construction nationally. We think this later second order impact improves the en
Companies: DRX NESF IES SAE
On 9 January last year, we set out our ten top stock picks for 2023, for what turned out to be another relatively poor twelve months for UK equities due to two wars, stubbornly high inflation and further tightening of monetary policy. This was even as other major markets, such as the US, largely recovered in the year. In the 2023 calendar year, the AIM All-Share index fell 8.2% and is still 42% off its 2021 high. From the release of our 2023 top picks note, the average total return (assuming div
Companies: PTAL GHH IGP MSLH PINE NXQ EQLS NXR AXL
Share: